Skin Delivery of Oestradiol from Deformable and Traditiona Liposomes: Mechanistic Studies

Journal of Pharmacy and Pharmacology - Tập 51 Số 10 - Trang 1123-1134 - 1999
Gamal M. El Maghraby1, Adrian C. Williams1, Brian Barry1
1Drug Delivery Group, Postgraduate Studies in Pharmaceutical Technology, The School of Pharmacy, University of Bradford, Bradford, BD7 1DP, UK

Tóm tắt

AbstractDeformable vesicles and traditional liposomes were compared as delivery systems for oestradiol to elucidate possible mechanisms of drug delivery through human skin. Accordingly, epidermal permeation of oestradiol from optimized deformable vesicles and traditional liposome formulations was studied under low dose non-occluded conditions. Five mechanisms were investigated. A free drug mechanism compared low-dose permeation through skin with drug release determined after separation of the free drug. Penetration enhancement was researched by studying skin pretreatment with empty vesicles. Improved drug uptake by skin was monitored by dipping stratum corneum into different formulations for 10 min and determining drug uptake. The possibility that intact vesicles permeate through the epidermis was tested by comparing permeation from 136-nm vesicles with that from > 500-nm vesicles, assuming that penetration depends on vesicle size. The possibility that different entrapment efficiencies in alternative formulations could be responsible for the difference in delivery was also evaluated.Lipid vesicles improved the skin delivery of oestradiol compared with delivery from an aqueous control. Maximum flux (Jmax) was increased 14- to 17-fold by use of deformable vesicles and 8.2- to 9.8-fold by use of traditional liposomes. Deformable vesicles were thus superior to traditional liposomes. Drug release was negligible over the period during which skin flux was maximum. Pretreatment with empty vesicles resulted in an enhancement ratio of 4.3 for pure phosphatidylcholine (PC) vesicles but the enhancement ratio ranged from only 0.8 to 2.4 for other formulations. Vesicles increased drug uptake into the stratum corneum 23- to 29-fold. Relative flux values obtained from small and large vesicles were similar. No correlation was found between entrapment efficiency and skin delivery.The results showed no evidence of a free drug mechanism, but revealed a possible penetration-enhancing effect for pure PC vesicles, although this was not the only mechanism operating. The positive uptake suggested that lipid vesicles increased drug partitioning into the skin. The data provided no evidence for in-vitro liposome penetration through skin as distinct from vesicle penetration into the stratum corneum.

Từ khóa


Tài liệu tham khảo

Akhter, 1984, An automated diffusion apparatus for studying skin penetration, Int. J. Pharm., 21, 17, 10.1016/0378-5173(84)90199-6

Artman, 1990, Liposomes from soya phospholipids as percutaneous drug carriers: Qualitative in vivo investigations with antibody-loaded liposomes, Arzneim. Forsch., 40, 1363

Artman, 1990, Liposomes from soya phospholipids as percutaneous drug carriers: Quantitative in vivo investigations with radioactivity, Arzneim. Forsch., 40, 1365

Barry, 1983, Dermatological Formulations: Percutaneous Absorption

Barry, 1987, Mode of action of penetration enhancers in human skin, J. Contr. Rel., 6, 85, 10.1016/0168-3659(87)90066-6

Bernard, 1995, Percutaneous absorption of new antiandrogen included in liposomes or in solution, Int. J. Pharm., 126, 235, 10.1016/0378-5173(95)04131-1

Cevc, 1992, Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradient and hydration force, Biochim. Biophys. Acta., 1104, 226, 10.1016/0005-2736(92)90154-E

Cevc, 1995, Transdermal drug carriers: basic properties, optimization and transfer efficiency in case of epicutaneously applied peptides, J. Contr. Rel., 36, 3, 10.1016/0168-3659(95)00056-E

Cevc, 1996, The skin: a pathway for systemic treatment with patches and lipid-based agent carriers, Adv. Drug Del. Rev., 18, 349, 10.1016/0169-409X(95)00091-K

Coderch, 1996, Percutaneous penetration of liposomes using the tape stripping technique, Int. J. Pharm., 139, 197, 10.1016/0378-5173(96)04620-0

Du Plessis, 1994, The influence of in vivo treatment of skin with liposomes on topical absorption of hydrophobic drug in vitro, Int. J. Pharm., 103, R1, 10.1016/0378-5173(94)90102-3

El Maghraby, 1998, Optimization of deformable vesicles for epidermal delivery of oestradiol, J. Pharm. Pharmacol., 50, 146, 10.1111/j.2042-7158.1998.tb02346.x

Fresta, 1996, Application of liposomes as potential cutaneous drug delivery systems. In vitro and in vivo investigation with radioactivity labelled vesicles, J. Drug Target., 4, 95, 10.3109/10611869609046267

Fry, 1978, Rapid separation of low molecular weight solutes from liposomes without dilution, J. Anal. Biochem., 90, 809, 10.1016/0003-2697(78)90172-0

Ganesan, 1984, Influence of liposomal drug entrapment on percutaneous absorption, Int. J. Pharm., 20, 139, 10.1016/0378-5173(84)90225-4

Harrison, 1984, Effect of freezing on human skin permeability, J. Pharm. Pharmacol., 36, 261, 10.1111/j.2042-7158.1984.tb04363.x

Hofland, 1995, Interaction between liposomes and human stratum corneum in vitro: freeze fracture electron microscopical visualization and small-angle X-ray scattering studies, Br. J. Dermatol., 132, 853, 10.1111/j.1365-2133.1995.tb16940.x

Kim, 1997, Targeted and sustained delivery of hydrocortisone to normal and stratum corneum-removed skin without enhanced skin absorption using a liposome gel, J. Contr. Rel., 46, 243, 10.1016/S0168-3659(96)01604-5

Kirjavainen, 1996, Interaction of liposomes with human skin in vitro—the inluence of lipid composition and structure, Biochim. Biophys. Acta., 1304, 179, 10.1016/S0005-2760(96)00126-9

Kligman, 1963, Preparation of isolated sheets of human stratum corneum, Arch. Dermatol., 88, 70, 10.1001/archderm.1963.01590240026005

Megrab, 1995, Oestradiol permeation through human skin and silastic membrane: effect of propylene glycol and supersaturation, J. Contr. Rel., 36, 277, 10.1016/0168-3659(95)00062-D

Mezei, 1992, Biodisposition of liposome-encapsulated active ingredients applied on the skin, 206

Mezei, 1980, Liposomes: a selective drug delivery system for the topical route of administration. I. Lotion dosage form, Life Sci., 26, 1473, 10.1016/0024-3205(80)90268-4

Mezei, 1982, Liposomes: a selective drug delivery system for the topical route of administration. Gel dosage form, J. Pharm. Pharmacol., 34, 473, 10.1111/j.2042-7158.1982.tb04767.x

New, 1990, Liposomes: A Practical Approach

Panico, 1993, Lipid vesicles loaded with thymopentin: characterization and in vitro activity on tumoral cells, Int. J. Pharm., 98, 19, 10.1016/0378-5173(93)90036-F

Paul, 1995, Transdermal immunization with large proteins by means of ultradeformable drug carriers, Eur. J. Immunol., 25, 3521, 10.1002/eji.1830251248

Touitou, 1994, Modulation of caffeine delivery by carrier design: liposomes versus permeation enhancers, Int. J. Pharm., 103, 131, 10.1016/0378-5173(94)90093-0

Warner, 1988, Electron probe analysis of human skin: determination of the water concentration profile, J. Invest. Dermatol., 90, 218, 10.1111/1523-1747.ep12462252

Wohlrab, 1989, Penetration of lecithin from hydrocortisone-containing liposomes into human skin, Dermatol. Mon. Schr., 175, 344

Thông tin
Thông tin xuất bản

Journal of Pharmacy and Pharmacology

Tập 51 Số 10

1123-1134

Thông tin tác giả